Cannabidiol in Veterinary Medicine: A Systematic Review of Efficacy, Safety, and Economic Considerations Compared to Conventional Treatments
Article Sidebar
Main Article Content
Abstract
This study presents a systematic literature review on the use of cannabidiol (CBD) in veterinary medicine, aiming to compare its efficacy, safety, and cost-effectiveness with conventional treatments. Analysis of 25 research articles published between 2013-2023 reveals that CBD demonstrates promising efficacy in managing pain, epilepsy, and anxiety in animals, with fewer side effects compared to conventional medications. However, most studies are limited by small sample sizes and short duration. Cost-effectiveness analyses indicate that despite higher initial costs, CBD may be more economical in the long term due to reduced side effects. Significant challenges include varying legal status across countries and ethical considerations, particularly for livestock. The review concludes that CBD shows potential as an alternative treatment in veterinary medicine, but further research is needed. Recommendations for future studies include long-term trials, broader species diversity, and investigation of drug interactions to ensure widespread and safe application in veterinary practice.
Article Details
References
Allais, M. G., & Humm, K. (2024). Intravenous fluid therapy compared to no treatment following blood donation in cats: a randomised controlled trial. Journal of Small Animal Practice, 65(9), 662-666. https://doi.org/10.1111/jsap.13760
Armadani, S.G., Wartiningsih, M. & Mellyanawati. (2024). Aspects that Influence Patient Satisfaction at the Elderly Clinic at Puskesmas X Surabaya. International Journal of Social Science Humanity & Management Research, 3(2), 11-18. https://doi.org/10.58806/ijsshmr.2024.v3i2n11
Charney, I. (2023). Rezoning a top-notch CBD: The choreography of land-use regulation and creative destruction in Manhattan’s East Midtown. Urban Studies, 61(8), 1451-1467. https://doi.org/10.1177/00420980231208623
Deabold, K.A., Schwark, W.S., Wolf, L. & Wakshlag, J.J. (2019). Single-Dose pharmacokinetics and preliminary safety assessment with use of CBD-Rich hemp nutraceutical in healthy dogs and cats. Animals, 9(10), 832. https://doi.org/10.3390/ani9100832
Ganguly, D. (2023). The Endocannabinoid System in the Immunobiology of Dendritic cells. In V. B. Patel, V. R. Preedy, & C. R. Martin (Eds.), Neurobiology and Physiology of the Endocannabinoid System (pp. 429-436). Academic Press. https://doi.org/10.1016/B978-0-323-90877-1.00020-6
Giuffrida, A., & Martinez, A. (2017). The Endocannabinoid System and Parkinson Disease. In E. Murillo-Rodríguez (Ed.), The Endocannabinoid System (pp. 63-81). Academic Press. https://doi.org/10.1016/B978-0-12-809666-6.00003-4
Knudsen, L.E. (2013). Animal-free toxicology: The use of human tissue to replace the use of animals examples from human biomonitoring and human placental transport studies. Alternatives to Laboratory Animals, 41(6), 443-447. https://doi.org/10.1177/026119291304100606
Kogan, L. (2016). Flexible Therapeutic Tools for Treating Nonhuman Animal Abusers. Society & Animals, 24(6), 639-642. https://doi.org/10.1163/1568530612341435
Lephart, E.D. (2023). Cannabidiol (CBD) with 4',7-Isoflavandiol (Equol) efficacy is greater than CBD or Equol treatment alone via human skin gene expression analysis. Frontiers in Bioscience-Landmark, 28(7), 154. https://doi.org/10.31083/j.fbl2807154
Liz Paola, N. Z., Torgerson, P. R., & Hartnack, S. (2022). Alternative paradigms in animal health decisions: A framework for treating animals not only as commodities. Animals (Basel), 12(14), 1845. https://doi.org/10.3390/ani12141845
Lloyd, E., Nguyen, N., & Hellman, J. (2023). The endocannabinoid system, immunomodulation, and LPS-induced inflammation. In V. B. Patel, V. R. Preedy, & C. R. Martin (Eds.), Neurobiology and Physiology of the Endocannabinoid System (pp. 17-34). Academic Press. https://doi.org/10.1016/B978-0-323-90877-1.00024-3
McPartland, J. M. (2017). Cannabis sativa and Cannabis indica versus “Sativa” and “Indica”. In S. Chandra, H. Lata, & M. A. ElSohly (Eds.), Cannabis sativa L. - Botany and Biotechnology (pp. 101-121). Springer International Publishing. https://doi.org/10.1007/978-3-319-54564-6_4
Mogi, C., Kawano, K., Mizuno, N. & Fukuyama, T. (2021). Use of Prednisolone, CBD and Behavior Modification as a Treatment for Atopic Dermatitis in a Canine: A Case Report. Journal of Alternative, Complementary & Integrative Medicine, 7, 207. https://doi.org/10.24966/ACIM-7562/100207
Montag, A. (2023). Indischer Hanf, syn. ‚Cannabis‘ (Cannabis sativa var. indica). In A. Montag (Ed.), Pflanzen und Haut : Dermatologisch bedeutsame Abwehrstrategien der Pflanzen in Europa (pp. 557-564). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-63014-3_62
Muratori, C. (2017). Real animals in ideal cities: the place and use of animals in renaissance Utopian literature. Renaissance Studies, 31(2), 223-239. https://doi.org/10.1111/rest.12294
Pamplona, F.A., Silva, L.R. & Coan, A.C. (2018). Potential clinical benefits of CBD-Rich cannabis extracts over purified CBD in treatment-resistant epilepsy: observational data meta-analysis. Frontiers in Neurology, 9, 759. https://doi.org/10.3389/fneur.2018.00759
Rahimi, V. B., & Askari, V. R. (2023). The endocannabinoid system and aging. In Patel, V. B., Preedy,V. R., & Martin,C. R. (Eds.), Neurobiology and Physiology of the Endocannabinoid System (pp. 53-65). Academic Press. https://doi.org/10.1016/B978-0-323-90877-1.00007-3
Raz, N., Heller, I., Lombardi, T., Marino, G., Davidson, E.M., & Eyal, A.M. (2022). Terpene-enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: case report. Frontiers in Pharmacology, 13, 979403. https://doi.org/10.3389/fphar.2022.979403
Rosner, M. & Nguyen, L. (2023). Can CBD Help To Combat COVID Variants?. The Science Breaker, 9(2), 1-3. https://doi.org/10.25250/thescbr.brk704
Sadaka, A.H., Canuel, J., Febo, M., Johnson, C.T., Bradshaw, H.B., Ortiz, R., Ciumo, F., Kulkarni, P., Gitcho, M.A. & Ferris, C. (2023). Effects of inhaled cannabis high in Δ9-THC or CBD on the aging brain: A translational MRI and behavioral study. Front Aging Neurosci. 15. https://doi.org/10.3389/fnagi.2023.1055433
Silvia, R., Plum, M. & Dufresne, R. (2020). Efficiencies and outcomes of depression treatment by a psychiatric pharmacist in a primary care clinic compared with treatment within a behavioral health clinic. Journal of the American Pharmacists Association, 60(5s), s98-s106. https://doi.org/10.1016/j.japh.2020.05.015
Skowronek, P., Wójcik, Ł. & Strachecka, A. (2022). CBD supplementation has a positive effect on the activity of the proteolytic system and biochemical markers of honey bees (Apis mellifera) in the Apiary. Animals,12(18),2313. https://doi.org/10.3390/ani12182313
Trigo, J.M. & Foll, B.L. (2017). The Role of the Endocannabinoid System in Addiction. In Eric, M. R. (Eds.), The Endocannabinoid System Genetics, Biochemistry, Brain Disorders, and Therapy (pp 187-236). Academic Press. https://doi.org/10.1016/B978-0-12-809666-6.00006-X
Tsvekova, D., Peykova, L., Dimitrova, L. A. & Pencheva, I. (2023) Regulation and control of the use of Cannabis and Cannabidiol in “novel foods”. Pharmacia, 70(4), 1385-1395. https://doi.org/10.3897/pharmacia.70.e114938
Turna, J., Syan, S.K., Frey, B.N., Rush, B., Costello, J., Weiss, M. & Mackillop, J. (2020). Cannabidiol as a Novel Candidate Alcohol use Disorder Pharmacotherary: a Systematic Review. Alcohol Clin Exp Res. 43(4), 550-563. https://doi.org/10.1111/acer.13964
Vogt, N. A., Sargeant, J. M., Stevens, C.P.G., & Dunn, J. N. (2019) A survey of veterinary student attitudes concerning whether marijuana could have therapeutic value for animals. PLOS ONE, 14(7), e0219430. https://doi.org/10.1371/journal.pone.0219430
